Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 13, 2024

BUY
$103.89 - $139.21 $2.96 Million - $3.97 Million
28,500 Added 57.0%
78,500 $10.8 Million
Q4 2023

Feb 09, 2024

SELL
$73.2 - $108.8 $3.16 Million - $4.7 Million
-43,200 Reduced 46.35%
50,000 $5.24 Million
Q3 2023

Nov 09, 2023

SELL
$94.53 - $112.68 $12.1 Million - $14.5 Million
-128,400 Reduced 57.94%
93,200 $8.81 Million
Q2 2023

Aug 11, 2023

SELL
$81.58 - $100.93 $18.9 Million - $23.4 Million
-231,800 Reduced 51.12%
221,600 $22.3 Million
Q1 2023

May 12, 2023

SELL
$74.68 - $85.82 $1.3 Million - $1.49 Million
-17,400 Reduced 3.7%
453,400 $36.8 Million
Q4 2022

Feb 08, 2023

BUY
$65.42 - $99.31 $26.5 Million - $40.2 Million
404,900 Added 614.42%
470,800 $35.2 Million
Q3 2022

Nov 10, 2022

SELL
$80.24 - $95.27 $1.65 Million - $1.96 Million
-20,600 Reduced 23.82%
65,900 $5.46 Million
Q2 2022

Aug 10, 2022

BUY
$76.05 - $123.38 $5.01 Million - $8.13 Million
65,900 Added 319.9%
86,500 $6.92 Million
Q1 2022

May 16, 2022

SELL
$108.37 - $120.0 $14.5 Million - $16.1 Million
-134,000 Reduced 86.68%
20,600 $2.33 Million
Q3 2019

Nov 14, 2019

BUY
$52.55 - $63.28 $1.3 Million - $1.56 Million
24,700 Added 19.01%
154,600 $8.82 Million
Q3 2018

Nov 14, 2018

BUY
$66.51 - $74.55 $7.99 Million - $8.96 Million
120,200 Added 1239.18%
129,900 $9.31 Million
Q2 2018

Aug 14, 2018

SELL
$62.77 - $73.47 $408,005 - $477,555
-6,500 Reduced 40.12%
9,700 $674,000
Q4 2017

Feb 14, 2018

SELL
$53.89 - $72.36 $3.44 Million - $4.62 Million
-63,800 Reduced 79.75%
16,200 $1.17 Million
Q3 2017

Nov 14, 2017

BUY
$56.13 - $64.78 $3.22 Million - $3.71 Million
57,300 Added 252.42%
80,000 $4.75 Million
Q2 2017

Aug 14, 2017

BUY
N/A
22,700
22,700 $1.47 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $14.2B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.